The role of p53 in treatment responses of lung cancer
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biochemistry,Biophysics
Reference111 articles.
1. Cancer burden in the year 2000. The global picture;Parkin;Eur. J. Cancer,2001
2. United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females;Travis;Cancer,1996
3. Recent advances in management of small-cell lung cancer;Chua;Cancer Treat. Rev.,2004
4. Multidisciplinary management of lung cancer;Spira;N. Engl. J. Med.,2004
5. Early detection of lung cancer: role of biomarkers;Brambilla;Eur. Respir. J.,2003
Cited by 139 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Insights into treatment-specific prognostic somatic mutations in NSCLC from the AACR NSCLC GENIE BPC cohort analysis;BMC Pulmonary Medicine;2024-07-02
2. Cymensifin A: a promising pharmaceutical candidate to defeat lung cancer via cellular reactive oxygen species-mediated apoptosis;Frontiers in Pharmacology;2024-04-11
3. Dissecting the pleiotropic roles of reactive oxygen species (ROS) in lung cancer: From carcinogenesis toward therapy;Medicinal Research Reviews;2024-01-29
4. Pair bonding and disruption impact lung transcriptome in monogamous Peromyscus californicus;BMC Genomics;2023-12-19
5. CSE1L is a negative regulator of the RB-DREAM pathway in p53 wild-type NSCLC and can be targeted using an HDAC1/2 inhibitor;Scientific Reports;2023-09-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3